The Contract Biomanufacturing Market Outlook to 2017

NEW YORK, March 7, 2013 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:

The Contract Biomanufacturing Market Outlook to 2017
http://www.reportlinker.com/p01118464/The-Contract-Biomanufacturing-Market-Outlook-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical

Introduction

The volume demand for biologics active pharmaceutical ingredients (API) from 2011-2017 is set to show a 20% annual increase. Combined with a boost in biosimilars, the biologics contract manufacturing market is forecast to grow 9% per year over the same period.

Scope

-- Develop a winning expansion and outsourcing strategy to grow your market share with forecasts through to 2017
-- Assess the areas to target and use your findings to help increase profits with information on drivers and resistors of outsourced biomanufacturing
-- Use the forecast for biologic and CMO market to adapt your strategy and ensure you're commercially successful
-- With analysis on the 5 leading players you will understand what your competitors are doing and what actions you can take to stay competitive
<highlights>The biological contract manufacturing organization (CMO) market will grow at a compound annual growth rate (CAGR) of 9.4% between 2011 and 2017. Mammalian contract manufacturing accounted for almost two thirds of the market in 2012, which was estimated at a size of $3bn.</highlights>

Increasing API demand driven by biologics market growth and an increase in the number of late-stage clinical trials and approved biotech products will be the biggest drivers of the bio-CMO market.

Reasons to Buy

-- What is the state of contract biomanufacturing in emerging regions?
-- Who are the leading bio-CMOs and what are their strategies, strengths and weaknesses?
-- What is the most attractive area of investment in the biologics market?

Table of Contents

Overview 4
Catalyst 4
-- Summary 4
Executive Summary 5
Market Overview 6
Definition 6
Segmentation 6
-- Categories of CMOs and services offered 7
References 9
Market Dynamics 10
Drivers 10
-- Growth of large molecule market 10
-- Cost savings 11
-- Risk reduction and risk sharing 11
-- Lead-time saving 11
-- Access to expertise and technology 12
-- Orphan drugs 12
-- Growth in emerging markets 13
-- Biosimilars 13
Resistors 14
-- Increasing yields and disposable technology 14
-- Overcapacity and pharma's increasing in-house capacity 14
-- Regulatory uncertainty over biosimilars 14
Market forecasts 15
-- Microbial and mammalian drug market 15
-- Microbial vs mammalian CMO market 15
-- Biosimilars 15
-- Biomanufacturing installed base 16
Contract biomanufacturing in emerging regions 17
References 17
Leading Players 19
Summary 19
Introduction 19
Boehringer Ingelheim 20
-- Overview and capabilities 20
-- Partnerships, deals, and expansion plans 20
-- SWOT analysis 21
Lonza 21
-- Overview and capabilities 21
-- Partnerships, deals, and expansion plans 22
-- SWOT analysis 22
Sandoz 23
-- Overview and capabilities 23
-- Partnerships, deals, and expansion plans 23
-- SWOT analysis 23
Fujifilm Diosynth Biotechnologies 24
-- Overview and capabilities 24
-- Partnerships, deals, and expansion plans 24
-- SWOT analysis 24
DSM 25
-- Overview and capabilities 25
-- Partnerships, deals, and expansion plans 25
-- SWOT analysis 26
References 26
Appendix 29
Methodology 29
-- Pharmaceutical market 29
-- Bio-CMO market 29
References 29
Table 1: Categories of CMOs and services offered 7
Figure 1: Biopharma value chain 7
Figure 2: Small vs large molecule pharma market ($bn), 2008-17 10
Figure 3: Number of orphan drug NMEs historically and
forecasted average in the US, 2005-16 12
Figure 4: Biopharmaceutical drug market by major product
group ($bn), 2011-17 15
Figure 5: Mammalian and microbial API CMO market ($bn),
2010-17 16
Figure 6: Comparison of leading bio-CMOs by capability 19

Companies Mentioned

First Aviation Services Inc., Hutchison 3G UK Limited

To order this report:
Biopharmaceutical Industry: The Contract Biomanufacturing Market Outlook to 2017

_________________________
Contact Clare: clare@reportlinker.com
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker